{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T09:59:28Z","timestamp":1773050368072,"version":"3.50.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007658","name":"Crohn\u2019s and Colitis Canada","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007658","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008794","name":"Research Manitoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008794","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Waugh Family Chair in Multiple Sclerosis"},{"name":"Bingham Chair in Gastroenterology"},{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","award":["#333252"],"award-info":[{"award-number":["#333252"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Tier 1 Canada Research Chair","award":["CRC-2017-00186"],"award-info":[{"award-number":["CRC-2017-00186"]}]},{"DOI":"10.13039\/100010318","name":"University of Manitoba","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010318","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Little is known about patterns of opioid prescribing in inflammatory bowel disease (IBD), but pain is common in persons with IBD. We estimated the incidence and prevalence of opioid use in adults with IBD and an unaffected reference cohort and assessed factors that modified opioid use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Using population-based health administrative data from Manitoba, Canada, we identified 5233 persons with incident IBD and 26\u2005150 persons without IBD matched 5:1 on sex, birth year, and region from 1997 to 2016. New and prevalent opioid prescription dispensations were quantified, and patterns related to duration of use were identified. Generalized linear models were used to test the association between IBD, psychiatric comorbidity, and opioid use adjusting for sociodemographic characteristics, physical comorbidities, and healthcare use.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Opioids were dispensed to 27% of persons with IBD and to 12.9% of the unaffected reference cohort. The unadjusted crude incidence per 1000 person-years of opioid use was nearly twice as high for the IBD cohort (88.63; 95% CI, 82.73-91.99) vs the reference cohort (45.02; 95% CI, 43.49-45.82; relative risk 1.97; 95% CI, 1.86-2.08). The incidence rate per 1000 person-years was highest in those 18-44 years at diagnosis (98.01; 95% CI, 91.45-104.57). The relative increase in opioid use by persons with IBD compared to reference cohort was lower among persons with psychiatric comorbidity relative to the increased opioid use among persons with IBD and reference cohort without psychiatric comorbidity.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion<\/jats:title>\n                  <jats:p>The use of opioids is more common in people with IBD than in people without IBD. This does not appear to be driven by psychiatric comorbidity.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ibd\/izae188","type":"journal-article","created":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T23:28:52Z","timestamp":1725406132000},"page":"386-393","source":"Crossref","is-referenced-by-count":4,"title":["Psychiatric Comorbidity Does Not Enhance Prescription Opioid Use in Inflammatory Bowel Disease as It Does in the General Population"],"prefix":"10.1093","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8041-3574","authenticated-orcid":false,"given":"Charles N","family":"Bernstein","sequence":"first","affiliation":[{"name":"Rady Faculty of Health Sciences, Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]},{"name":"IBD Clinical and Research Centre, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D","family":"Fisk","sequence":"additional","affiliation":[{"name":"Nova Scotia Health and the Departments of Psychiatry, Psychology & Neuroscience, and Medicine, Dalhousie University , Halifax, Nova Scotia ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randy","family":"Walld","sequence":"additional","affiliation":[{"name":"Rady Faculty of Health Sciences, Manitoba Centre for Health Policy, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M","family":"Bolton","sequence":"additional","affiliation":[{"name":"Rady Faculty of Health Sciences, Department of Psychiatry, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitender","family":"Sareen","sequence":"additional","affiliation":[{"name":"Rady Faculty of Health Sciences, Department of Psychiatry, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott B","family":"Patten","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, Cumming School of Medicine, University of Calgary , Calgary, Alberta ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Singer","sequence":"additional","affiliation":[{"name":"Rady Faculty of Health Sciences, Department of Family Medicine, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8685-3212","authenticated-orcid":false,"given":"Lisa M","family":"Lix","sequence":"additional","affiliation":[{"name":"Rady Faculty of Health Sciences, Department of Community Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A","family":"Hitchon","sequence":"additional","affiliation":[{"name":"Rady Faculty of Health Sciences, Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9e","family":"El-Gabalawy","sequence":"additional","affiliation":[{"name":"Rady Faculty of Health Sciences, Department of Clinical Health Psychology, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]},{"name":"Rady Faculty of Health Sciences, Department of Anesthesiology, Perioperative Medicine and Pain, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Katz","sequence":"additional","affiliation":[{"name":"Rady Faculty of Health Sciences, Manitoba Centre for Health Policy, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]},{"name":"Rady Faculty of Health Sciences, Department of Family Medicine, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]},{"name":"Rady Faculty of Health Sciences, Department of Community Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley A","family":"Graff","sequence":"additional","affiliation":[{"name":"IBD Clinical and Research Centre, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]},{"name":"Rady Faculty of Health Sciences, Department of Clinical Health Psychology, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1855-5595","authenticated-orcid":false,"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[{"name":"Rady Faculty of Health Sciences, Department of Internal Medicine, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]},{"name":"IBD Clinical and Research Centre, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]},{"name":"Rady Faculty of Health Sciences, Department of Community Health Sciences, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth Ann","family":"Marrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jitender","family":"Sareen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott B","family":"Patten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Singer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M","family":"Lix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A","family":"Hitchon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9e","family":"El-Gabalawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D","family":"Fisk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles N","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"Graff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Berrigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Zarychanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Peschken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Marriott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaarina","family":"Kowalec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Berrigan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"issue":"11-12","key":"2025021012305295700_CIT0001","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/apt.17241","article-title":"Urgency for bowel movements is a highly discriminatory symptom of active disease in persons with inflammatory bowel disease (The Manitoba Living with IBD Study)","volume":"56","author":"Kulyk","year":"2022","journal-title":"Aliment Pharmacol Therap."},{"issue":"9","key":"2025021012305295700_CIT0002","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/j.cgh.2011.05.016","article-title":"Common symptoms and stressors among individuals with inflammatory bowel diseases","volume":"9","author":"Singh","year":"2011","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"2","key":"2025021012305295700_CIT0003","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/ibd\/izy235","article-title":"Increased burden of psychiatric disorders in inflammatory bowel disease","volume":"25","author":"Bernstein","year":"2019","journal-title":"Inflamm Bowel Dis."},{"issue":"11","key":"2025021012305295700_CIT0004","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/j.biopsych.2010.01.014","article-title":"Induction of depressed mood disrupts emotion regulation neurocircuitry and enhances pain unpleasantness","volume":"67","author":"Berna","year":"2010","journal-title":"Biol Psychiatry."},{"issue":"12","key":"2025021012305295700_CIT0005","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1093\/ibd\/izad017","article-title":"Proton-pump inhibitor use before and after a diagnosis of inflammatory bowel disease","volume":"29","author":"Singh","year":"2023","journal-title":"Inflamm Bowel Dis."},{"issue":"5","key":"2025021012305295700_CIT0006","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1038\/ajg.2009.15","article-title":"Do NSAIDs, antibiotics, infections or stress trigger flares in IBD","volume":"104","author":"Singh","year":"2009","journal-title":"Am J Gastroenterol."},{"issue":"11","key":"2025021012305295700_CIT0007","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1046\/j.1440-1746.2001.02468.x","article-title":"Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics","volume":"16","author":"Edwards","year":"2001","journal-title":"J Gastroenterol Hepatol."},{"issue":"10","key":"2025021012305295700_CIT0008","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1111\/j.1572-0241.2005.00256.x","article-title":"Narcotic use in patients with Crohn\u2019s disease","volume":"100","author":"Cross","year":"2005","journal-title":"Am J Gastroenterol."},{"issue":"4","key":"2025021012305295700_CIT0009","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1097\/ALN.0000000000000768","article-title":"Psychiatric comorbidity is associated prospectively with diminished opioid analgesia and increased opioid misuse in patients with chronic low back pain","volume":"123","author":"Wasan","year":"2015","journal-title":"Anesthesiology."},{"issue":"3","key":"2025021012305295700_CIT0010","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/pds.4929","article-title":"Long-term opioid therapy definitions and predictors: a systematic review","volume":"29","author":"Karmali","year":"2020","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"2","key":"2025021012305295700_CIT0011","doi-asserted-by":"publisher","first-page":"e220194","DOI":"10.1001\/jamanetworkopen.2022.0194","article-title":"Risk of opioid overdose associated with concomitant use of oxycodone and selective serotonin reuptake inhibitors","volume":"5","author":"Yunusa","year":"2022","journal-title":"JAMA Netw Open."},{"issue":"10","key":"2025021012305295700_CIT0012","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1038\/ajg.2014.230","article-title":"The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis","volume":"109","author":"Targownik","year":"2014","journal-title":"Am J Gastroenterol."},{"issue":"10208","key":"2025021012305295700_CIT0013","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/S0140-6736(19)32229-9","article-title":"Global patterns of opioid use and dependence: harms to populations, interventions, and future action","volume":"394","author":"Degenhardt","year":"2019","journal-title":"Lancet."},{"issue":"10","key":"2025021012305295700_CIT0014","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/oxfordjournals.aje.a009735","article-title":"The epidemiology of Crohn\u2019s disease and ulcerative colitis in a central Canadian province: a population-based study","volume":"149","author":"Bernstein","year":"1999","journal-title":"Am J Epidemol."},{"issue":"4","key":"2025021012305295700_CIT0015","doi-asserted-by":"publisher","first-page":"276","DOI":"10.7326\/M14-2559","article-title":"The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop","volume":"162","author":"Chou","year":"2015","journal-title":"Ann Intern Med."},{"key":"2025021012305295700_CIT0016","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jpsychores.2016.08.014","article-title":"Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease","volume":"89","author":"Marrie","year":"2016","journal-title":"J Psychosom Res."},{"issue":"1","key":"2025021012305295700_CIT0017","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1186\/s13104-017-2958-1","article-title":"Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data","volume":"10","author":"Marrie","year":"2017","journal-title":"BMC Res Notes"},{"key":"2025021012305295700_CIT0018","author":"WHO Collaborating Centre for Drug Statistics Methodology"},{"issue":"2","key":"2025021012305295700_CIT0019","doi-asserted-by":"publisher","first-page":"e043930","DOI":"10.1136\/bmjopen-2020-043930","article-title":"Medication adherence in multiple sclerosis as a potential model for other chronic diseases: a population-based cohort study","volume":"11","author":"Evans","year":"2021","journal-title":"BMJ Open."},{"issue":"2","key":"2025021012305295700_CIT0020","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1136\/jnnp-2022-329508","article-title":"Prescription opioid use in multiple sclerosis","volume":"94","author":"Marrie","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"8 Suppl 2","key":"2025021012305295700_CIT0021","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1007\/BF03403825","article-title":"Learning from the census: the Socio-Economic Factor Index (SEFI) and health outcomes in Manitoba","volume":"103","author":"Chateau","year":"2012","journal-title":"Can J Public Health."},{"issue":"1","key":"2025021012305295700_CIT0022","first-page":"53","article-title":"Ambulatory care groups: a categorization of diagnoses for research and management","volume":"26","author":"Starfield","year":"1991","journal-title":"Health Serv Res."},{"issue":"5","key":"2025021012305295700_CIT0023","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1111\/1475-6773.01029","article-title":"Assessing population health care need using a claims-based ADG morbidity measure: a validation analysis in the province of Manitoba","volume":"37","author":"Reid","year":"2002","journal-title":"Health Serv Res."},{"issue":"5","key":"2025021012305295700_CIT0024","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.cgh.2020.08.041","article-title":"Opioid use among patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"19","author":"Niccum","year":"2021","journal-title":"Clin Gastroenterol Hepatol."},{"issue":"1","key":"2025021012305295700_CIT0025","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6501e1","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"65","author":"Dowell","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2025021012305295700_CIT0026","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.bpa.2006.12.004","article-title":"The impact of opioid-induced hyperalgesia for postoperative pain","volume":"21","author":"Koppert","year":"2007","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"10","key":"2025021012305295700_CIT0027","doi-asserted-by":"publisher","first-page":"265","DOI":"10.15585\/mmwr.mm6610a1","article-title":"Characteristics of initial prescription episodes and likelihood of long-term opioid use\u2014United States, 2006\u20132015","volume":"66","author":"Shah","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"1","key":"2025021012305295700_CIT0028","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/apt.15023","article-title":"Incidence and predictors of new persistent opioid use following inflammatory bowel disease flares treated with oral corticosteroids","volume":"49","author":"Noureldin","year":"2019","journal-title":"Aliment Pharmacol Ther."},{"issue":"6","key":"2025021012305295700_CIT0029","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1136\/flgastro-2023-102423","article-title":"Opioid use and associated factors in 1676 patients with inflammatory bowel disease: a multicentre quality improvement project","volume":"14","author":"Baillie","year":"2023","journal-title":"Frontline Gastroenterol."},{"key":"2025021012305295700_CIT0030","doi-asserted-by":"publisher","first-page":"izad256","DOI":"10.1093\/ibd\/izad256","article-title":"Impact of opioid use on the natural history of inflammatory bowel disease. Prospective longitudinal follow up study","author":"Riggott","year":"2023","journal-title":"Inflamm Bowel Dis."},{"issue":"2","key":"2025021012305295700_CIT0031","doi-asserted-by":"publisher","first-page":"323","DOI":"10.14309\/ajg.0000000000002497","article-title":"Older adult-onset of inflammatory bowel diseases is associated with higher utilization of analgesics: a Nationwide Cohort Study","volume":"119","author":"Dalal","year":"2024","journal-title":"Am J Gastroenterol."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/advance-article-pdf\/doi\/10.1093\/ibd\/izae188\/59004000\/izae188.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/2\/386\/59004000\/izae188.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/31\/2\/386\/59004000\/izae188.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T12:38:31Z","timestamp":1739191111000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/31\/2\/386\/7748321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,9,3]]},"published-print":{"date-parts":[[2025,2,10]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izae188","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2024,9,3]]}}}